FDG PET/CT in colorectal cancer.

Authors :: Rodríguez-Fraile M
Cózar-Santiago MP
Sabaté-Llobera A
Caresia-Aróztegui AP
Delgado Bolton RC
Orcajo-Rincon J
de Arcocha-Torres M
García-Velloso MJ
García-Talavera P
Source :: Revista espanola de medicina nuclear e imagen molecular [Rev Esp Med Nucl Imagen Mol (Engl Ed)] 2020 Jan - Feb; Vol. 39 (1), pp. 57-66. Date of Electronic Publication: 2019 Nov 24.
Publication Year :: 2020
Abstract: Colorectal cancer is the third most frequent cancer worldwide. Although its incidence is increasing, mainly in those aged under50, mortality has decreased by 50% in the more developed countries, principally due to the adoption of new practices in prevention, diagnosis and treatment. In particular, the various diagnostic imaging modalities allow improved therapeutic decision-making, evaluation of the response and early detection of recurrence. The aim of this paper is to review the available scientific evidence on the value of positron emission tomography with <superscript>18</superscript> F-FDG ( <superscript>18</superscript> F-FDG PET/CT) in the colorectal cancer, with special emphasis on the indications of the guidelines and recommendations of the main international scientific associations regarding this imaging technique.<br /> (Copyright © 2019 Sociedad Española de Medicina Nuclear e Imagen Molecular. Publicado por Elsevier España, S.L.U. All rights reserved.)